Drugs / Donor Hematopoietic Stem and Progenitor Cell Infusion
Donor Hematopoietic Stem and Progenitor Cell Infusion
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT07269041 | Feb 2026 → Jan 2029 expected | disease related to solid organ transplantation, liver failure | University of California, Los Angeles | Recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Donor Hematopoietic Stem and Progenitor Cell Infusion | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07269041 ↗ |
| Modality | Cell therapy | “infusion of mobilized donor hematopoietic stem and progenitor cells” NCT07269041 ↗ |